Cardiometabolic Equipment For Medical Specialties
-
based in USA
Why Inhaled Therapies: Delivery of therapeutics directly to the lungs allows for more precise doses of drugs to achieve therapeutic benefit and avoid adverse events seen with orals and injectables. For a number of cardiopulmonary and cardiometabolic conditions, treatment via inhalation is an ideal alternative to routine injections allowing for improved drug bioavailability and efficacy while ...
-
Manufactured by Olink Proteomicsbased in SWEDEN
The most comprehensive, high-performance protein biomarker panel available for cardiovascular and metabolic ...
-
Manufactured by A-Mansiabased in BELGIUM
Akkermansia muciniphila is a species of microbe found in the human gut microbiota. Akkermansia muciniphila MucT was first isolated from human feces in 2004, in the laboratory of Prof. Willem M. de Vos (Wageningen University – The Netherlands) by Dr. Muriel Derrien. The identified strain was then deposited in the American Type Culture Collection (ATCC) under the reference ATCC® ...
-
Manufactured by Darnitsa Groupbased in UKRAINE
Valsartan is an active specific angiotensin II receptor antagonist for oral use. It selectively influences AT1 subtype receptors responsible for the known effects of angiotensin II. Elevated plasma angiotensin II levels after AT1 receptor blockade by valsartan can stimulate the unblocked AT2 receptor that balances the effect of the AT1 receptor. Valsartan does not show any partial agonist ...
-
Manufactured by Olink Proteomicsbased in SWEDEN
Casting a broader net to further explore the complexity of the human proteome. Complementing and expanding on our previous portfolio of disease area-focused biomarker panels, our exploratory panels offers scientists the chance to cast a wider net in the quest to identify new biomarkers and relevant protein signatures, offering many new assays focused on important biological processes with ...
-
Manufactured by Omni-Bioticbased in USA
Omni-Biotic Hetox is a probiotic supplement specifically developed to provide effective gut-liver axis and detoxification ...
-
Manufactured by IBSA Farmaceutici Italia Srlbased in ITALY
Cardiology is the branch of medicine involving the study, diagnosis and treatment of acquired or congenital cardiovascular diseases, which represent the primary cause of mortality and morbidity in Western countries. In addition to treating cardiovascular diseases, heart failure and rhythm disorders, cardiologists also deal with cardiovascular prevention. Over the past two decades, there has been ...
-
Manufactured by Lumen Bioscience, Inc.based in USA
Cardiometabolic disease (CMD)—a cluster of related conditions that includes obesity, diabetes, and cardiovascular disease—afflicts hundreds of millions of people worldwide, and the associated health and economic burdens continue to grow. An estimated 17.9 million people died from CMD in 2019, representing nearly a third of all global deaths. Of these deaths, 85% were due to heart ...
-
Manufactured by Boston Pharmaceuticalsbased in USA
BOS-704 is a ghrelin O-acyl transferase inhibitor with therapeutic potential for multiple ...
-
based in USA
We developed a soft mist inhaled human insulin for the treatment of Type 1 and 2 diabetes. Clinical data based on our five Phase 1/2a studies demonstrated AER-501 has: Faster onset and similar profile when compared to lispro. Intra and inter-subject variability similar to injections. Minimal to no cough following inhalation. These clinical studies also demonstrated the AFINA drop dispenser ...
-
Manufactured by Boston Pharmaceuticalsbased in USA
BOS-467 has the potential to reduce hepatic fat and fibrosis. BOS-467 is a humanized β-klotho agonist monoclonal antibody that mimics FGF21 biology. ...
-
Manufactured by Boston Pharmaceuticalsbased in USA
BOS-580 has the potential to reduce hepatic fat and fibrosis. BOS-580 is an injectable, genetically engineered variant of human fibroblast growth factor 21 (FGF21). ...
-
Manufactured by Boston Pharmaceuticalsbased in USA
BOS-857 is a first-in-class, inhaled, small molecule furin inhibitor with therapeutic potential in pulmonary diseases, including cystic fibrosis (CF), vascular diseases, and infectious ...
-
Manufactured by Darnitsa Groupbased in UKRAINE
Rosuvastatin is a selective and competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methylglutaryl coenzyme A to mevalonate, a precursor of cholesterol. The primary site of action of rosuvastatin is the liver, the target organ for cholesterol lowering. Rosuvastatin increases the number of hepatic low-density lipoprotein (LDL) receptors on the cell ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you